Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Annals of Surgical Oncology
Erschienen in: Annals of Surgical Oncology 11/2008

01.11.2008 | Gastrointestinal Oncology

Oncological Outcome After Local Excision of Rectal Carcinomas

verfasst von: Thomas Borschitz, MD, Ines Gockel, MD, Ralf Kiesslich, MD, Theodor Junginger, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Local excision (LE) of T1 rectal cancer yields low recurrence rates. However, more frequent recurrences with unknown states of high-risk T1/T2 tumors are risk factors. The purpose of this study was to evaluate if, after LE, immediate reoperation is required, or awaiting salvage surgery is sufficient.

Methods

150 T1 and 42 T2 tumors were treated by LE. Immediate reoperation was attempted for unfavorable pT1 (G3-4/L1/V1/R1/Rx/R ≤1 mm) and all pT2 tumors. Three groups were formed. Group A included low-risk pT1 tumors after complete (R0) LE; unfavorable pT1 and all T2 tumors were divided in groups B (immediate reoperation) and C (salvage surgery).

Results

Groups A (n = 93) and B (n = 39) showed high tumor-free (TFS) and tumor-related survival (TRS) rates: group A 92% and 98%; group B 86% and 89%. In group C (n = 43), the TFS und TRS were significantly lower with 54% and 72%. Group A showed low recurrence rates and a wide range of International Union Against Cancer (UICC) stages. In group B, similarly low recurrence rates were found, but, in contrast, all recurrences were UICC IV. Group C had significantly higher recurrences rates and, in addition, two-thirds of these patients showed advanced UICC stages (III–IV).

Conclusions

LE of low-risk T1 tumors represents an adequate therapy. Immediate reoperation after LE of pT1 tumors with unfavorable histological finding or pT2 tumors can avoid local recurrences. Thereafter, high TFS rates can be expected in these patients, but metastases cannot be prevented and adjuvant measures are necessary. Awaiting recurrences as in group C leads to bad oncological outcomes with high recurrences and low survival rates.
Literatur
1.
Borschitz T, Junginger T. Value of local surgical therapy of rectal cancer. A literature analysis. Zentralbl Chir 2003;128:1066–74PubMedCrossRef
2.
Borschitz T, Heintz A, Junginger T. The influence of histopathologic criteria on the long-term prognosis of locally excised pT1 rectal carcinomas: results of local excision (transanal endoscopic microsurgery) and immediate reoperation. Dis Colon Rectum 2006;49:1492–506; discussion 1500–05PubMedCrossRef
3.
Bretagnol F, Merrie A, George B, et al. Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg 2007;94:627–33PubMedCrossRef
4.
Duek SD, Krausz MM, Hershko DD. Transanal endoscopic microsurgery for rectal cancer. Isr Med Assoc J 2005;7:435–8PubMed
5.
Faivre J, Chaume J, Pigot F, et al. Transanal electroresection of small rectal cancer: a sole treatment? Dis Colon Rectum 1996;39:270–8PubMedCrossRef
6.
Ganai S, Kanumuri P, Rao RS, et al. Local recurrence after transanal endoscopic microsurgery for rectal polyps and early cancers. Ann Surg Oncol 2006;13:547–56PubMedCrossRef
7.
Gonzalez QH, Heslin MJ, Shore G, et al. Results of long-term follow-up for transanal excision for rectal cancer. Am Surg 2003;69:675–8PubMed
8.
Hahnloser D, Wolff BG, Larson DW, et al. Immediate radial resection after local excision of rectal cancer: an oncologic compromise? Dis Colon Rectum 2005;48:429–37PubMedCrossRef
9.
Kim DG, Madoff RD. Transanal treatment of rectal cancer: ablative methods and open resection. Semin Surg Oncol 1998;15:101–13PubMedCrossRef
10.
Koscinski T, Malinger S, Drews M. Local excision of rectal carcinoma not exceeding the muscularis layer. Colorectal Dis 2003;5:159–63PubMedCrossRef
11.
Langer C, Markus P, Liersch T, et al. UltraCision or high-frequency knife in transanal endoscopic microsurgery (TEM)? Advantages of a new procedure. Surg Endosc 2001;15:513–7PubMedCrossRef
12.
Lee W, Lee D, Choi S, et al. Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 2003;17:1283–7PubMedCrossRef
13.
Maslekar S, Pillinger SH, Monson JR. Transanal endoscopic microsurgery for carcinoma of the rectum. Surg Endosc 2007;21:97–102PubMedCrossRef
14.
Marks JH, Marchionni C, Marks GJ. Transanal endoscopic microsurgery in the treatment of select rectal cancers or tumors suspicious for cancer. Surg Endosc 2003;17:1114–7PubMedCrossRef
15.
Mentges B, Buess G, Effinger G, et al. Indications and results of local treatment of rectal cancer. Br J Surg 1997;84:348–51PubMedCrossRef
16.
Middleton PF, Sutherland LM, Maddern GJ. Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum 2005;48:270–84PubMedCrossRef
17.
Nakagoe T, Sawai T, Tsuji T, et al. Local rectal tumor resection results: gasless, video-endoscopic transanal excision versus the conventional posterior approach. World J Surg 2003;27:197–202PubMed
18.
Schäfer H, Baldus SE, Gasper F, et al. Submucosal infiltration and local recurrence in pT1 low-risk rectal cancer treated by transanal endoscopic microsurgery. Chirurg 2005;76:379–84PubMedCrossRef
19.
Sengupta S, Tjandra JJ. Local excision of rectal cancer: what is the evidence? Dis Colon Rectum 2001;44:1345–61PubMedCrossRef
20.
21.
Slisow W, Moesta KT, Schlag PM. Local excision of rectal cancer through windowed specula: long-term results. Recent Result Cancer Res 1998;146:114–23
22.
Suzuki H, Furukawa K, Kan H, et al. The role of transanal endoscopic microsurgery for rectal tumors. J Nippon Med Sch 2005;72:278–84PubMedCrossRef
23.
Winde G, Nottberg H, Keller R, et al. Surgical cure for early rectal carcinomas (T1): transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 1996;39:969–76PubMedCrossRef
24.
Benson R, Wong CS, Cummings BJ, et al. Local excision and postoperative radiotherapy for distal rectal cancer. Int J Radiat Oncol Biol Phys 2001;50:1309–16PubMed
25.
Borschitz T, Heintz A, Junginger T. Transanal endoscopic microsurgical excision of pT2 rectal cancer: Results and possible indications. Dis Colon Rectum 2007;50:292–301PubMedCrossRef
26.
Chakravarti A, Compton CC, Shellito PC, et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 1999;230:49–54PubMedCrossRef
27.
Friel CM, Cromwell JW, Marra C, et al. Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum 2002;45:875–9PubMedCrossRef
28.
Garcia-Aguilar J, Mellgren A, Sirivongs P, et al. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 2000;231:345–51PubMedCrossRef
29.
Lamont JP, McCarty TM, Digan RD, et al. Should locally excised T1 rectal cancer receive adjuvant chemoradiation? Am J Surg 2000;180:402–6PubMedCrossRef
30.
Mellgren A, Sirivongs P, Rothenberger DA, et al. Is local excision adequate therapy for rectal cancer? Dis Colon Rectum 2000;43:1064–74PubMedCrossRef
31.
Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg 2002;236:522–9PubMedCrossRef
32.
Taylor RH, Hay JH, Larsson SN. Transanal local excision of selected low rectal cancer. Am J Surg 1998;175:360–3PubMedCrossRef
33.
Wagman R, Minsky BD, Cohen AM, et al. Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. Int J Radiat Oncol Biol Phys 1999;44:841–6PubMed
34.
Gopaul D, Belliveau P, Vuong T, et al. Outcome of local excision of rectal carcinoma. Dis Colon Rectum 2004;47:1780–8PubMedCrossRef
35.
Endreseth BH, Myrvold HE, Romundstad P, et al. The Norwegian Rectal Cancer Group. Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum 2005;48:1380–8PubMedCrossRef
36.
Langer C, Liersch T, Suss M, et al. Surgical cure for early rectal carcinoma and large adenoma: transanal endoscopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical resection. Int J Colorectal Dis 2003;18:222–9PubMed
37.
Bouvet M, Milas M, Giacco GG, et al. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol 1999;6:26–32PubMedCrossRef
38.
Le Voyer TE, Hoffman JP, Cooper H, et al. Local excision and chemoradiation for low rectal T1 and T2 cancers is an effective treatment. Am Surg 1999;65:625–30PubMed
39.
Minsky BD, Enker WE, Cohen AM, et al. Local excision and postoperative radiation therapy for rectal cancer. Am J Clin Oncol 1994;17:411–6PubMedCrossRef
40.
Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys 2000;46:313–22PubMedCrossRef
41.
Saclarides TJ. Transanal endoscopic microsurgery: a single surgeon’s experience. Arch Surg 1998;133:595–8PubMedCrossRef
42.
Steele GD Jr, Herndon JE, Bleday R, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 1999;6:433–41PubMedCrossRef
43.
Willett CG. Local excision followed by postoperative radiation therapy. Semin Radiat Oncol 1998;8:24–9PubMedCrossRef
44.
Buess G, Hutterer F, Theiss J, et al. A system for a transanal endoscopic rectum operation. Chirurg 1984;55:677–80PubMed
45.
Hermanek P. A pathologist’s point of view on endoscopically removed polyps of the colon and rectum. Acta Hepatogastroenterol (Stuttg) 1978;25:169–70
46.
Coverlizza S, Risio M, Ferrari A, et al. Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer 1989;64:1937–47PubMedCrossRef
47.
Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437–59PubMedCrossRef
48.
Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 1986;39:585–9PubMedCrossRef
49.
Soreide O, Norstein J, Fielding LP, et al. International standardisation and documentation of the treatment of rectal cancer. In Soreide O, Norstein J (eds): Rectal Cancer Surgery. Optimisation—Standardisation—Documentation. Springer, Berlin 1997
50.
American Joint Committee on Cancer (AJCC). Cancer staging manual, 6th edition. (Greene FL, Page DL, Fleming ID, et al., eds) New York, Berlin, Heidelberg, AJCC: Springer, 2002
51.
UICC. TNM classification of malignant tumors, 6th edition. (Sobin LH, Wittekind Ch, eds). New York: Wiley, 2002
52.
Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 2005;242:472–7; discussion 477–9PubMed
53.
Floyd ND, Saclarides TJ. Transanal endoscopic microsurgical resection of pT1 rectal tumors. Dis Colon Rectum 2006;49:164–8PubMedCrossRef
54.
Helgstrand F, Iversen E, Bech K. Transanal endoscopic microsurgery. The latest 5 years’ experience in Roskilde County. Ugeskr Laeger 2007;169:1784–8PubMed
55.
Wirsing K, Lorenzo-Rivero S, Luchtefeld M, et al. Local excision of stratified T1 rectal cancer. Am J Surg 2006;191:410–2PubMedCrossRef
56.
Madbouly KM, Remzi FH, Erkek BA, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Dis Colon Rectum 2005;48:711–9; discussion 719–21PubMedCrossRef
57.
Whitehouse PA, Armitage JN, Tilney HS, et al. Transanal endoscopic microsurgery: local recurrence rate following resection of rectal cancer. Colorectal Dis 2008;10:187–93PubMed
58.
Baron PL, Enker WE, Zakowski MF, et al. Immediate vs. salvage resection after local treatment for early rectal cancer. Dis Colon Rectum 1995;38:177–81PubMedCrossRef
59.
Nakagoe T, Ishikawa H, Sawai T, et al. Long-term outcomes of radical surgery after gasless video endoscopic transanal excision of T1/T2 rectal cancers. Eur J Surg Oncol 2004;30:638–42PubMedCrossRef
60.
Weiser MR, Landmann RG, Wong WD, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 2005;48:1169–75PubMedCrossRef
61.
Lopez-Kostner F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001;44:173–8PubMedCrossRef
62.
Ambacher T, Kasperk R, Schumpelick V. Tumor recurrence after transanal excision of stage I rectal cancer in comparison with radical resection. Chirurg 1990;70:1469–74CrossRef
63.
Willett CG, Compton CC, Shellito PC, et al. Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer 1994;73:2716–20PubMedCrossRef
64.
Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291–304
65.
Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985;312:1465–72
66.
Hobday TJ. An overview of approaches to adjuvant therapy for colorectal cancer in the United States. Clin Colorectal Cancer 2005;5:11–8CrossRef
67.
Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709–15PubMed
68.
Minsky BD. Adjuvant therapy for rectal cancer—the transatlantic view. Colorectal Dis 2003;5:416–22PubMedCrossRef
69.
NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–50CrossRef
70.
O’Connell MJ, Laurie JA, Kahn M, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 1998;16:295–300PubMed
71.
Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 1997;84:1130–5PubMedCrossRef
Metadaten
Titel
Oncological Outcome After Local Excision of Rectal Carcinomas
verfasst von
Thomas Borschitz, MD
Ines Gockel, MD
Ralf Kiesslich, MD
Theodor Junginger, MD
Publikationsdatum
01.11.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0113-x

Weitere Artikel der Ausgabe 11/2008

Annals of Surgical Oncology 11/2008 Zur Ausgabe

Gastrointestinal Oncology

Quality of Life after Potentially Curative Treatment for Locally Advanced Rectal Cancer

Gastrointestinal Oncology

Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of Relapse

Endocrine Tumors

Prophylactic Lymph Node Dissection in Papillary Thyroid Carcinoma

Gastrointestinal Oncology

Preoperative Resolution of Jaundice Following Biliary Stenting Predicts More Favourable Early Survival in Resected Pancreatic Ductal Adenocarcinoma

Gastrointestinal Oncology

Hidden Opportunities in Cytoreductive Surgery for Peritoneal Carcinomatosis of Colorectal Origin

Breast Oncology

Radiofrequency Thermal Ablation of Breast Cancer Local Recurrence: A Phase II Clinical Trial

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.